Details for Patent: 5,023,082

Summary for Patent: 5,023,082

Title:	Sustained-release pharmaceutical compositions
Abstract:	The present invention pertains to biodegradable sustained-release composins capable of achieving the sustained release of a pharmaceutical or other agent. The compositions can be formed into implant devices which may be used to treat a wide variety of diseases and conditions. The implants are especially useful in treating diseases such as periodontal disease which require prolonged drug release.
Inventor(s):	Friedman; Michael (Jerusalem, IL), Steinberg; Doron (Jerusalem, IL), Soskolne; Aubrey (Jerusalem, IL)
Assignee:	Yissum Research Development Company of the Hebrew University of Jerusalem (Jerusalem, IL)
Application Number:	07/175,623
Patent Claim Types: see list of patent claims	Composition; Use; Device;

Drugs Protected by US Patent 5,023,082

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

Foreign Priority and PCT Information for Patent: 5,023,082

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Israel	78826	May 18, 1986

International Family Members for US Patent 5,023,082

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	80996
Australia	605487
Australia	7480687
Canada	1307463